OnCo

Stay in the loop

Leave your email and OnCo will write when something big changes in cancer research. No spam, one click to unsubscribe.

Email updates open shortly. Until then, press Watch on any page to keep it on your list.

drugsTreatmentPhase 2

Balstilimab

aka AGEN2034

Balstilimab is a monoclonal antibody from Agenus Inc., in registered phase 2 trials for colorectal cancer.